Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2105b9682ef875ab2d232684e85f8260 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-74 |
filingDate |
2005-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f1674324007f3c5d5a52c645b420f39 |
publicationDate |
2010-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7713935-B2 |
titleOfInvention |
Compounds that modulate TRH actions |
abstract |
The invention relates to compounds that inhibit thyrotropin-releasing hormone (TRH) degrading ectoenzyme and/or enhance, and/or mimic the biological actions of TRH. The compounds find therapeutic application, particularly in conditions involving neuronal cell injury and disturbances in neurobiological function. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015361136-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016509200-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873717-B2 |
priorityDate |
2004-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |